Summit Therapeutics Inc is a biotechnology business based in the US. Summit Therapeutics shares (SMMT) are listed on the NASDAQ and all prices are listed in US Dollars. Summit Therapeutics employs 79 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Summit Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SMMT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Summit Therapeutics stock price (NASDAQ: SMMT)Use our graph to track the performance of SMMT stocks over time.
Summit Therapeutics shares at a glance
|Latest market close||$7.82|
|52-week range||$3.14 - $10.99|
|50-day moving average||$7.18|
|200-day moving average||$6.60|
|Wall St. target price||$4.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.23|
Buy Summit Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Summit Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Summit Therapeutics price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||9.37%|
|3 months (2021-04-28)||23.34%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Summit Therapeutics financials
|Gross profit TTM||$860,000|
|Return on assets TTM||-32.54%|
|Return on equity TTM||-96.82%|
|Market capitalisation||$771.1 million|
TTM: trailing 12 months
Shorting Summit Therapeutics shares
There are currently 810,542 Summit Therapeutics shares held short by investors – that's known as Summit Therapeutics's "short interest". This figure is 104.5% up from 396,260 last month.
There are a few different ways that this level of interest in shorting Summit Therapeutics shares can be evaluated.
Summit Therapeutics's "short interest ratio" (SIR)
Summit Therapeutics's "short interest ratio" (SIR) is the quantity of Summit Therapeutics shares currently shorted divided by the average quantity of Summit Therapeutics shares traded daily (recently around 371808.25688073). Summit Therapeutics's SIR currently stands at 2.18. In other words for every 100,000 Summit Therapeutics shares traded daily on the market, roughly 2180 shares are currently held short.
However Summit Therapeutics's short interest can also be evaluated against the total number of Summit Therapeutics shares, or, against the total number of tradable Summit Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Summit Therapeutics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Summit Therapeutics shares in existence, roughly 10 shares are currently held short) or 0.0329% of the tradable shares (for every 100,000 tradable Summit Therapeutics shares, roughly 33 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Summit Therapeutics.
Find out more about how you can short Summit Therapeutics stock.
Summit Therapeutics share dividends
We're not expecting Summit Therapeutics to pay a dividend over the next 12 months.
Summit Therapeutics share price volatility
Over the last 12 months, Summit Therapeutics's shares have ranged in value from as little as $3.14 up to $10.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Summit Therapeutics's is 0.6175. This would suggest that Summit Therapeutics's shares are less volatile than average (for this exchange).
Summit Therapeutics overview
Summit Therapeutics Inc. , a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also develops DDS-01 series to treat infection caused by the bacteria Neisseria gonorrhoeae through Discuva platform; and DDS-04 series to treat Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts. .
Stocks similar to Summit Therapeutics
Summit Therapeutics in the news
Riverview Trust Co Buys IAC/InterActiveCorp, Schwab US Dividend Equity ETF, Unum Group, Sells Seagate Technology Holdings PLC, IAC/InterActiveCorp, BTC BlackRock Short Maturity Bond ETF
Entasis Therapeutics appoints Anna Diaz Triola as CCO
Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Preservation, for its Investigational Drug Ridinilazole
Frequently asked questionsWhat percentage of Summit Therapeutics is owned by insiders or institutions?
Currently 74.078% of Summit Therapeutics shares are held by insiders and 9.762% by institutions. How many people work for Summit Therapeutics?
Latest data suggests 79 work at Summit Therapeutics. When does the fiscal year end for Summit Therapeutics?
Summit Therapeutics's fiscal year ends in January. Where is Summit Therapeutics based?
Summit Therapeutics's address is: One Broadway, Cambridge, MA, United States, 02142 What is Summit Therapeutics's ISIN number?
Summit Therapeutics's international securities identification number is: US86627T1088 What is Summit Therapeutics's CUSIP number?
Summit Therapeutics's Committee on Uniform Securities Identification Procedures number is: 86627R102
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert